Interim Report 1st Quarter 2017/18 (1 June 2017 – 31

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
137
Interim Report 1st Quarter 2017/18 (1 June 2017 – 31 August 2017)

Company Announcement No 17.11 - Struer, 2017-10-04 08:00 CEST (GLOBE NEWSWIRE) --  

Q1 highlights

“In the first quarter, we saw double-digit growth across both business units and we improved our profitability. We launched several new, innovative products, increased brand partnering activities, and continued to strengthen our business model. Overall, we have had a satisfactory start and we are on track for the year”, says CEO Henrik Clausen.

The Group realised a revenue growth of 15 per cent, driven by double-digit growth in both Bang & Olufsen (13 per cent) and B&O PLAY (17 per cent) In the quarter, the Bang & Olufsen business unit launched BeoLab 50 and BeoVision Eclipse. B&O PLAY launched E8 and E4. Together with the existing product portfolio and BeoSound Shape, which is now available in stores, the company has a strong foundation for the coming quarters.

Brand partnering remains an important driver of both licence income as well as brand awareness. In the first quarter, the company announced new collaborations with LG on the new V30 flagship smartphone, and with HARMAN to deliver an audio system to Bentley Motors’ Continental GT. The Group gross margin increased to 39.9 per cent from 33.4 per cent driven by higher revenue, resulting in a higher indirect cost absorption, increased income from brand partnering, improved product margins and a change in the product mix. As expected, capacity costs increased by 15 per cent due to higher depreciations on capitalised development costs related to the TV portfolio. Excluding the effect from the higher depreciations, capacity costs increased by 2 per cent.

Incurred development costs and capitalisations of development projects were particularly high in the quarter, due to the final development of the BeoVision Eclipse. These costs are expected to decrease significantly in the coming quarters.

Due to the seasonal nature of the business, EBITDAC was negative DKK 42 million, but still constitutes an improvement from negative DKK 67 million last year. The increase in revenue and improved gross margin contributed to an improvement in profitability.

In line with expectations, free cash flow was negative DKK 159 million compared to negative DKK 32 million last year. The change was due to product launches driving higher inventory and trade receivables as well as increased investments in products and the Innovation Lab in Struer.

The outlook for 2017/18 remains unchanged. The Group expects to continue the growth momentum and increase revenue by around 10 per cent compared to 2016/17, and to increase the underlying EBITDAC margin to 8-10 per cent in 2017/18. The Group’s free cash flow is expected to be positive in 2017/18.

Any enquiries about this announcement can be addressed to:

Investor contact, Claus Højmark Jensen, tel.: +45 2325 1067

Press contact, Jens Bjørnkjær Gamborg, tel.: +45 2496 9371

A webcast will be hosted on 4 October 2017 at 10:00 CET. Access to the webcast is obtained through our website www.bang-olufsen.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 6

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Salveo Home Care Faces Class Action Over Labor Violations

Updated Category News Views 4

Another Company Lands in Hot Water Alright, it looks like Salveo Home Care is in the spotlight for all the wrong reasons. The home care provider—which should have been minding its P's and Q's—is now facing a class action suit. Why, you ask? Well, for allegedly skimping on wages and dodging legal obligations that leave their employees hanging dry. The Allegations are...

Continue Reading
DKS Facing Class Action Over Stock Slump Allegations

Updated Category News Views 1

A Burst Bubble at DICK'S Sporting Goods Grit your teeth and hang on—DICK'S Sporting Goods has stumbled, and investors are supposed to just weather the storm. From September 8, 2025, through August 24, 2026, if you held DICK'S shares, you've got some explaining to do, or at least you better start reading the fine print. Take note, folks: the deadline to file for lead...

Continue Reading
Revamping Children's Radiotherapy: Leo Cancer Care's Vision

Updated Category News Views 1

The latest buzz in pediatric radiotherapy is shaking things up, and it’s all thanks to a game-changing shift in how treatment is delivered to kids. We're eyeballing Leo Cancer Care's innovative approach that might just redefine how these young patients face their battles. Standing Tall: A New Chapter in Proton Therapy In June, Stanford Medicine dished out the first...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 6

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
AI Memory Growth Pushes Limits at GMIF2026 Summit

Updated Category News Views 1

The Memory and Storage Race in the AI Era The 5th GMIF2026 Innovation Summit wrapped up in Shenzhen, and boy, was it a heavyweight bout. You could practically feel the tension in the room as industry giants sparred over the future of memory and storage in AI. This wasn't just another trade show pow-wow; this was a strategic chess match over where AI infrastructure is...

Continue Reading
Accuray, Samsung Push Boundaries with Imaging Deal

Updated Category News Views 1

In a move that's got the healthcare industry buzzing, Accuray Incorporated (NASDAQ: ARAY) announced its partnership with Samsung NeuroLogica to supercharge the CyberKnife® System. This isn't just another collaboration; it's a strategic pivot to advance imaging capabilities, marrying Samsung's volumetric innovations with Accuray's established precision in robotic...

Continue Reading
Melrose Fire Station Reaches Steel Topping Milestone

Updated Category News Views 0

Metal and Milestones: A New Era for Melrose Rolling into Melrose, Massachusetts, there's some serious action kicking off with the new Fire Engine 2 Station reaching a steel topping milestone. This phase isn't just about slapping on another beam; it's the crescendo of diligent teamwork from all the hands involved—from CTA Construction Managers to the clout of Ironworkers...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 4

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading

Top 5 Most Recently Viewed Articles

Compass Therapeutics Pursues Growth with New Public Offering

Updated Category News Views 134

Compass Therapeutics Initiates Public Offering Compass Therapeutics, Inc. (NASDAQ: CMPX), a dynamic and innovative biopharmaceutical company at the forefront of developing antibody-based therapies for cancer treatment, has announced the initiation of an underwritten public offering. This move aims to bolster its financial foundation to facilitate the advancement of its...

Continue Reading
Whirlpool Corporation Declares Substantial Quarterly Dividend

Updated Category News Views 312

Whirlpool Corporation Announces Quarterly Dividend Today, the board of directors of Whirlpool Corporation has declared a quarterly dividend of $1.75 per share on the Company's common stock. This dividend showcases the company's commitment to returning value to its shareholders. It will be payable on June 15, 2025, to stockholders of record at the close of business on May...

Continue Reading
How Tastytrade and Zerohash Transformed Account Funding

Updated Category News Views 312

Tastytrade Enables Instant Stablecoin Funding for Traders Tastytrade, the innovative online brokerage firm designed specifically for self-directed investors, has taken a significant leap forward in enhancing the trading experience. By partnering with Zerohash, they have rolled out an advanced stablecoin account funding option. This cutting-edge method allows traders...

Continue Reading
AKVA Group ASA's Strategic Buyback Program for Shares

Updated Category News Views 155

AKVA Group ASA Initiates Share Buyback Program In a recent announcement, AKVA Group ASA has taken a significant step towards enhancing its shareholder value by initiating a buyback program for up to 60,000 of its own shares. This strategic move is part of the company's plan to reinvest in its workforce through an employee share program, thereby fostering a stronger...

Continue Reading
Nvidia Stock: A Buying Opportunity Amid Market Fluctuations

Updated Category News Views 125

Nvidia Stock Sees Pre-Market Decline Shares of Nvidia Corporation (NASDAQ: NVDA) experienced a decline of 2.01% during the pre-market trading session. This drop followed the company's announcement that it had no revenue from H20 chip sales in China. This news has created some concerns among investors, although industry analysts see potential in the current situation....

Continue Reading